For citations:
THE FDA HAS APPROVED THE THE FIRST DRUG FOR THE CONGENITAL FORM OF THROMBOTIC THROMBOCYTOPENIC PURPURA. Pediatric pharmacology. 2023;20(6):609. (In Russ.)
THE FDA HAS APPROVED THE THE FIRST DRUG FOR THE CONGENITAL FORM OF THROMBOTIC THROMBOCYTOPENIC PURPURA. Pediatric pharmacology. 2023;20(6):609. (In Russ.)